Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2014 Apr 1.
Published in final edited form as: Arch Womens Ment Health. 2012 Dec 27;16(2):101–108. doi: 10.1007/s00737-012-0321-z

Concurrent levels of maternal salivary cortisol are unrelated to self-reported psychological measures in low-risk pregnant women

Kristin M VOEGTLINE 1, Kathleen A COSTIGAN 2, Katie T KIVLIGHAN 1, Mark L LAUDENSLAGER 3, Janice L HENDERSON 2, Janet A DIPIETRO 1
PMCID: PMC3671921  NIHMSID: NIHMS431637  PMID: 23269500

Abstract

Associations between salivary cortisol and maternal psychological distress and well-being were examined prospectively on 112 women with normally progressing, singleton pregnancies between 24 and 38 weeks gestation. At each of 5 visits, conducted in 3-week intervals, women provided a saliva sample and completed questionnaires measuring trait anxiety, depressive symptoms, pregnancy-specific hassles and uplifts, and psychological well-being. Maternal salivary cortisol was unrelated to psychological measures with the exception of minor associations detected with measures of anxiety and depressive symptoms between 30 and 32 weeks only. Findings indicate that self-reported maternal psychological distress and well-being are not associated with significant variation in maternal salivary cortisol levels during the second half of gestation. This suggests that studies that measure psychological factors in pregnancy but do not measure maternal cortisol should exercise caution in assuming activation of the maternal hypothalamic-pituitary-adrenal (HPA) axis is the mechanism through which maternal psychological factors are transduced to the fetus.

Keywords: Cortisol, Pregnancy, Maternal stress, Fetal programming

Introduction

No discussion of the growth and development of the baby would be complete without consideration of the old belief that the mental condition of the mother may modify the development of the unborn infant, or, as they say, “mark” it.” (Eastman 1951, p.36)

The notion that maternal emotional state during pregnancy – worry, sadness, or happiness – impacts the developing fetus has long-standing historical origins. There is tremendous current academic interest in the relation between maternal psychological factors and pregnancy and infant outcomes. Although immune and inflammatory mechanisms have been proposed as potential links between maternal psychological factors and birth outcomes, most studies that detect associations implicate the physiological action of the hypothalamic pituitary adrenal (HPA) axis as the putative link (Cottrell and Seckl 2009; Kramer et al. 2009; Mulder et al. 2002; Sandman et al. 1997; Wadhwa et al. 2011). The HPA axis regulates the production of maternal cortisol. While a substantial proportion of cortisol (80-90%) is metabolized by the placenta during gestation, maternal concentrations have significant impact on fetal levels and cortisol in excess may directly reach the fetus unmetabolized (Gitau et al. 1998). As such, maternal cortisol has been termed the ‘culprit prenatal stress variable’ (Field and Diego 2008).

Regulation of the maternal HPA axis changes dramatically during pregnancy. Baseline cortisol levels increase across gestation, reaching levels that are two to fourfold greater than pre-pregnancy concentrations prior to delivery (Allolio et al. 1990; Mastorakos and Ilias 2003; Sandman et al. 2006). Placental production of corticotropin-releasing hormone (CRH) is an antecedent for observed elevations in maternal cortisol secretion during late pregnancy. Placental CRH exerts a strong regulatory influence on maternal adrenal function via hypothalamic inputs of the central nervous system, stimulating a positive feedback loop between hormone outputs of the maternal HPA axis and placenta (Chan et al. 1993; Petraglia et al. 1996; Stalla et al. 1989). At the same time, increased circulating maternal cortisol acts to down regulate hypothalamic production of CRH, inducing a negative feedback loop within the maternal central nervous system, and contributes to a dampening of the maternal physiological activation to external stressors with advancing gestation (Magiakou et al. 1996). Thus, the degree to which maternal emotions or psychological factors may affect the amount of cortisol to which the fetus is exposed is unknown.

A number of studies have failed to detect positive associations between a variety of measures of maternal psychological distress and maternal cortisol levels (Davis and Sandman 2010; Goedhart et al. 2010; Gutteling et al. 2006; Harville et al. 2009; King et al. 2010; Petraglia et al. 2001; Rothenberger et al. 2011; Sikkema et al. 2001). While most have focused on negative psychological factors in so far as they are theorized to increase maternal cortisol, a few have examined the physiological benefit of behavioral well-being during pregnancy. Results revealed a modest inverse association between positive life events and lower maternal awakening cortisol in late pregnancy and, consistent with others, no association with negative life events (Pluess et al. 2012). Both general and pregnancy specific social support are also modestly and inversely related to maternal cortisol in mid-gestation (Wadhwa et al. 1996).

Despite this, maternal HPA activity continues to be the proposed link between prenatal psychological stress and birth outcome in numerous conceptual models (Dunkel-Schetter 2011; Gennaro and Hennessy 2003; Wadhwa 2005). Some of the null findings of the lack of association between cortisol and psychological distress measures cited in the previous paragraph are buried in results describing other relationships with outcomes and not the focus of that report. Others involve study designs which may be viewed as limited in their ability to detect such associations due to the inclusion of only a single measure to assess maternal psychological function (Petraglia et al. 2001) or only one or two data points (Harville et al. 2009; Sikkema et al. 2001). The current study provides a multidimensional assessment of maternal psychological factors using five standard measures that assess both negative and positive maternal characteristics including trait anxiety, depressive symptoms, pregnancy-specific hassles and uplifts, and psychological well-being. These data were collected at each of five successive visits during pregnancy concomitant with measurement of maternal salivary cortisol utilizing a staggered-cohort design spanning 24 to 38 weeks gestation. We hypothesize that a) there will be intraindividual stability in measures of maternal cortisol and psychological functioning within pregnant women over time, and b) variation in maternal cortisol level will be unrelated to variation in maternal psychological factors.

Materials and Methods

Participants

Participants were 112 normotensive, non-smoking women with normally progressing, singleton pregnancies and no pre-existing medical complications known to complicate pregnancy (e.g., Type 1 diabetes) or infant outcome (e.g., malformations). Women were recruited through advertisements posted in a local university and hospital. During the course of the study, five participants developed gestational diabetes, six women developed pregnancy induced hypertension (PIH), and four women delivered mildly preterm (M = 36.2 weeks, range = 35 to 36 weeks). Table 1 presents sociodemographic characteristics which reflect a sample of well-educated, mature, married, and predominantly primiparous women. Pregnancy dating was based on last menstrual period and early confirmation by ultrasound. As expected from the nature of the sample, pregnancy was diagnosed relatively early (M = 4.8 weeks, SD = 1.2) followed by clinical confirmation (M = 8.1 weeks, SD = 2.0). Fifty-one percent of the offspring were female and all had normal birth outcomes (M gestational age at delivery = 39.4 weeks, SD = 1.2; M birth weight = 3443 grams, SD = 436). Approximately one quarter of the infants were delivered via Cesarean section (N = 26, 23%).

Table 1.

Maternal sociodemographic characteristics (n = 112)

Variable % M ± SD
Maternal age (years) 31.2 ± 4.6
Maternal education (years) 17.2 ± 2.1
Pre-pregnancy body mass index 23.6 ± 4.3
Maternal race
 Caucasian 80
 African-American 13
 Asian 7
Married 91
Primiparous 72

Procedure

To fully represent the gestational age span from 24 to 38 weeks gestation, participants were stratified into three cohorts with staggered entry into the protocol between 24 and 26 weeks gestation and tested in 3-week intervals. Each cohort included between 34 and 39 participants. Prenatal visits were scheduled at 13:00 h or 15:00 h. During each of the 5 prenatal visits, women provided saliva samples and completed five psychological questionnaires (described below), in addition to participating in a maternal-fetal monitoring period as part of the larger protocol, reported elsewhere (DiPietro et al. 2010). The study was approved by the university’s Institutional Review Board and women provided written, informed consent.

Measures

Salivary cortisol

Saliva was collected approximately 0.5 h after arrival to the laboratory at each visit. Participants were instructed to eat no more than 1.5 h prior to arrival and to restrict fluid intake upon visit arrival prior to collection to avoid the possibility of contaminating substances in the saliva. Participants moistened a filter paper strip (2.5 cm x 9.0 cm, Whatman Grade 42) which was subsequently air dried and stored at room temperature. This procedure has been validated, showing cortisol remains stable in this dried format and yields comparable recovery rates (92%) to whole saliva (Neu et al. 2007), and has been used previously in pregnant women (Kivlighan et al. 2008). Salivary cortisol concentration is unaffected by saliva flow rate (Vining and McGinley 1987). Dried filters were cut and extracted in assay buffer using a commercial high sensitivity EIA kit (Salimetrics, LLC) that detects cortisol levels in the range of 0.003—3.0 micrograms/dl (0.083—82.77 nmol/L). The detection limit after accounting for the extraction dilution was 0.018 micrograms/dl (0.50 nmol/L). Inter-assay coefficients of variation were less than 9.0% for high and low range laboratory controls. Intra-assay coefficients of variation for duplicate determinations were less than 4.5% in this laboratory. Raw values were log transformed for data analyses.

Psychological functioning

The following psychological questionnaires were administered at each visit:

Anxiety

Trait anxiety was evaluated by the Spielberger Trait Anxiety Scales (Y-2; STAI), one of the most extensively validated self-administered anxiety measures and the most commonly used measure of anxiety in studies of pregnancy (Spielberger 1983). The STAI includes twenty items, scored on a 4-point Likert scale, ranging from 1 (almost never) to 4 (almost always) where higher scores reflect greater trait anxiety. A median alpha reliability coefficient of 0.90 for this scale has been reported (Spielberger 1983).

Depressive symptoms

The Center for Epidemiologic Survey Depression Scale (CES-D) was used to index depressive symptoms (Radloff 1977). The CES-D is a widely-used 20-item self-report measure of depressive symptoms experienced over the past week. Each item is rated on a 4-point scale ranging from 0 (rarely or none of the time) to 3 (most or all of the time) and summed to create a total score. The CES-D has been used in numerous studies of the perinatal period, and Cronbach alpha values ranging from 0.83 to 0.88 reflect high internal reliability during pregnancy (Mercer and Ferketich 1988; Mosack and Shore 2006).

Pregnancy-specific hassles and uplifts

Pregnancy-specific stress was assessed by a shortened form of the previously validated Pregnancy Experiences Scale (PES) (DiPietro et al. 2004). The PES-Brief includes the 10 most frequently endorsed hassles and uplifts from the long form of the PES, each rated on the original 4-point scale, ranging from 0 (not at all) to 3 (a great deal). Items were scored and averaged to derive perceived intensity of hassles and uplifts, with higher values reflecting greater intensity. The abbreviated PES-Brief demonstrates comparable psychometric integrity to the original version; internal reliability alphas were equal or greater to .80 (DiPietro et al. 2008).

Well-being

Emotional well-being was assessed using the World Health Organization Five Well-being Index (WHO-5) (WHO 2008), a 5-item self-report measure that has been validated in non-pregnant samples (de Wit et al. 2007; Heun et al. 1999).

Statistical analyses

Preliminary analyses evaluated the role of pregnancy risk factors and sociodemographic variables including maternal race, education and parity as potential confounders using t-tests and Pearson correlation coefficients, as appropriate. Descriptive information regarding change over gestation for maternal cortisol and psychological measures was provided using hierarchical linear models (HLM; SAS Mixed). Data analysis was focused on examining the interrelationship among the five individual psychological measures and their stability over time as well as the association between maternal cortisol values and the psychological measures utilizing Pearson correlation coefficients. Exploratory analyses revealed that time of day of saliva sample collection was associated with cortisol values (rs = -0.21 to -0.31, p < 0.05), such that collection in the earlier afternoon time slot showed slightly higher salivary cortisol concentrations. As a result, partial correlations between cortisol and psychological measures, adjusted for time of day, were also conducted.

Computing individual correlation coefficients at each of the 15 gestational weeks with each of the five psychological measures would significantly inflate the possibility of detecting spurious associations and minimize ns; as a result data analysis was conducted by collapsing the cohorts into five gestational periods. That is, period 1 included data collected at 24, 25, or 26 weeks gestation; period 2 included data collected at 27, 28, or 29 weeks gestation; and so on. There was minor variation in sample size per gestational period due to missed visits or missing data by some participants at some gestational ages (see Table 2).

Table 2.

Descriptive information for maternal measures and change over time

24-26 wksa
M (SD)
27-29 wksb
M (SD)
30-32 wksc
M (SD)
33-35 wksd
M (SD)
36-38 wkse
M (SD)
t * p value
Salivary cortisol (ug/dl) 0.18 (0.09) 0.20 (0.10) 0.20 (0.10) 0.22 (0.13) 0.25 (0.11) 5.56 < 0.001
Psychological factors
 Trait anxiety 31.19 (6.64) 31.68 (7.79) 31.17 (7.65) 31.41 (8.45) 31.94 (8.02) 1.08 0.283
 Depressive symptoms 6.06 (4.65) 8.71 (7.85) 8.93 (7.26) 9.25 (7.28) 10.33 (7.10) 6.80 < 0.001
 Pregnancy-specific hassles 1.37 (0.43) 1.38 (0.43) 1.42 (0.48) 1.40 (0.46) 1.43 (0.43) 1.30 0.196
 Emotional well-being 13.01 (2.92) 12.83 (3.31) 12.52 (3.33) 12.36 (3.63) 12.24 (3.50) −2.76 0.007
 Pregnancy-specific uplifts 2.31 (0.47) 2.34 (0.46) 2.44 (0.45) 2.38 (0.48) 2.40 (0.46) 2.38 0.019
a

n = 105-107

b

n = 98-100

c

n = 94

d

n = 98-101

e

n = 86-87

*

n = 112 for hierarchical linear modeling (HLM) test of change over time

Results

Sample means and standard deviations for maternal cortisol and psychological measures at each visit are reported in Table 2. Raw cortisol values are presented for interpretation; log-transformed cortisol values to correct for skew were used in all data analyses. Examination of cortisol and psychological values for the four women that delivered mildly preterm revealed no pattern of outliers among these cases and comparable means to that of the larger sample (e.g., cortisol 33 to 35 weeks: M mild preterm = 0.19, SD = 0.13, M sample = 0.22, SD = 0.13; anxiety 33 to 35 weeks: M slight preterm = 32.5, SD = 8.0, M sample = 31.4, SD = 8.5), and as such they were not excluded from the analyses. Cortisol and psychological measures were similarly unrelated to the development of pregnancy-induced hypertension (n = 6). The five women with gestational diabetes showed higher cortisol levels at the first visit (t (103) = -2.54, p < 0.05) but not thereafter; there were no differences in report of psychological distress and well-being in these women compared to the larger sample. With respect to sociodemographic variables, maternal cortisol and psychological factors were unrelated to either maternal race or parity at any gestational period with one exception: African-American women (n = 15) reported higher pregnancy uplifts in the first two gestational periods (24 to 26 weeks and 27 to 29 weeks GA, ps < .05). At two gestational periods (27 to 29 weeks and 33 to 35 weeks GA), higher maternal education was associated with lower CESD scores and, and at a single gestational period (27 to 29 weeks GA) with lower trait anxiety and cortisol level (ps < .05). Adjusting for the partial correlation of maternal education did not impact the magnitude or significance of associations between maternal psychological measures and cortisol. As a result, sociodemographic variables were not included in the final models.

Change in maternal salivary cortisol and psychological measures across gestation

HLM analyses were conducted to examine change across the second half of gestation; data are presented in Table 2. Gestational trends for cortisol (DiPietro et al. 2011) and select psychological measures (i.e., anxiety and pregnancy-specific hassles and uplifts) (DiPietro et al. 2010) or composite measures only (Mendelson et al. 2011), have been reported previously. Maternal cortisol increased significantly from 24 to 38 weeks, controlling for time of day of saliva collection. Of the measures of maternal distress, only the CESD, which includes items reflective of normal consequences of pregnancy including fatigue and restless sleep significantly increased across the second half of gestation. With respect to positive emotions, maternal pregnancy uplifts significantly increased while general emotional well-being declined.

Associations among psychological measures

At each measurement, measures of distress (i.e., anxiety, depressive symptoms and PES hassles) were positively correlated with each other (rs = 0.40 to 0.84, p < 0.01), as were measures of well-being (i.e., WHO and PES uplifts; rs = 0.27 to 0.42, p < 0.01). Distress and well-being measures (exclusive of the PES-Brief) were negatively related (rs = -0.55 to -0.77, p < 0.01). Because of the strong interrelations between positive and negative attributes and the presumption that any individual measure does not fully reflect psychological distress, the individual psychological measures were Z-scored (i.e., normalized) and averaged to create composite measures of maternal psychological distress (STAI, CES-D, PES-Brief Hassles) and well-being (WHO-5, PES-Brief Uplifts).

Across measurement occasions, there was considerable stability in maternal cortisol levels (range rs = 0.44 to 0.68) such that while these levels increased across pregnancy for all women, individuals generally retained their rank. Psychological measures were also stable within individual women: trait anxiety (range rs = 0.74 to 0.92), depressive symptoms (range rs = 0.52 to 0.81), pregnancy-specific hassles (range rs = 0.44 to 0.77), well-being (range rs = 0.63 to 0.81), and pregnancy-specific uplifts (range rs = 0.68 to 0.79).

Associations between maternal cortisol and psychological measures

Table 3 shows the unadjusted inter-correlations between maternal salivary cortisol levels and psychological measures of distress and well-being at each visit. The only significant, albeit modest, correlations between measures of maternal psychological distress and cortisol levels were found during the third gestational period. Women who reported more anxiety or depressive symptoms between 30 to 32 weeks gestation had higher cortisol levels (rs = 0.21 and 0.23, respectively). No other associations, for individual measures or either composite, reached significance at any gestational period. Adjustment for diurnal salivary cortisol trends related to time of day yielded a small reduction in the strength of these two significant correlations (anxiety: r = 0.20, p = 0.05; depressive symptoms: r = 0.22, p < 0.05) and an overall similar pattern of negligible associations with the remaining variables and at other gestational ages.

Table 3.

Interrelationships of maternal cortisol and psychological status

Maternal salivary cortisol (ug/dl)

24-26 wks 27-29 wks 30-32 wks 33-35 wks 36-38 wks
Psychological measures
 Trait anxiety −0.02 0.06 0.21* 0.09 0.21
 Depressive symptoms −0.01 0.13 0.23 0.18 0.08
 Pregnancy-specific hassles 0.06 0.05 0.10 0.06 0.09
Distress composite 0.02 0.09 0.20 0.11 0.15
 Emotional well-being 0.11 −0.01 −0.10 −0.10 0.01
 Pregnancy-specific uplifts 0.05 −0.05 −0.19 0.13 −0.18
Well-being composite 0.10 −0.04 −0.17 0.02 −0.11

p<0.10

*

p<0.05

Discussion

Maternal salivary cortisol and measures of maternal psychological distress and well-being show significant within-person stability during the second half of pregnancy suggesting that both may exert chronic influence on the intrauterine context. However, in contrast to the common assumption that maternal psychological characteristics, as measured by paper and pencil assessments, are transduced to the fetus via action of the maternal HPA axis, levels of salivary cortisol were essentially unrelated to self-reported maternal anxiety, depressive symptoms, and pregnancy-specific stress or to measures of well-being.

Despite perhaps a general perception to the contrary, these results are consistent with those reported previously which failed to detect significant associations between cortisol and psychological functioning in samples of pregnant women (Davis and Sandman 2010; Gutteling et al. 2006; Harville et al. 2009; Petraglia et al. 2001). Harville et al. (2009) found no correlations larger than r = 0.15 between salivary cortisol and a wide range of psychosocial measures including perceived stress, state-trait anxiety, coping style, life events, social support, and pregnancy-specific anxiety measured during two gestational windows (15 to 19 weeks and 25 to 29 weeks). Similarly, Petraglia and colleagues (2001) did not find any evidence for a significant relationship between serum cortisol and psychological stress at 28 weeks gestation. Studies that included either a greater number of samples across a wider gestational window (i.e. 15 to 37 weeks) (Davis and Sandman 2010) or multiple cortisol assessments during the course of a day to assess diurnal decline (Gutteling et al. 2006), also failed to detect significant associations.

The current study detected significant associations between salivary cortisol and trait anxiety and depressive symptoms between 30 and 32 weeks (rs = 0.21 to 0.23). The magnitude of these relations is consistent with a significant finding reported elsewhere of correlations between maternal cortisol and perceived stress (rs = 0.18) measured in the first and second trimesters (Rothenberger et al. 2011). With respect to indicators of maternal well-being, we did not find evidence to suggest a significant association between emotional well-being and pregnancy uplifts with salivary cortisol (highest r = -0.19), although the direction of the association followed the same inverse patterns observed elsewhere (Pluess et al. 2012; Wadhwa et al. 1996). Although these associations may attain statistical significance at times, they reflect less than 6% of shared variance. Correlations of this magnitude are of questionable physiological significance, particularly in light of background normative changes in the regulation of the maternal HPA axis during pregnancy (Allolio et al. 1990; Mastorakos and Ilias 2003). The typical top-down regulation of the maternal HPA axis via hypothalamic inputs of the central nervous system is subject to the ascending influence of placental CRH (Chan et al. 1993; Petraglia et al. 1996; Stalla et al. 1989). Placental CRH stimulates HPA activity, resulting in uniform elevations in maternal baseline cortisol measured in serum and saliva, independent of the maternal psychological environment.

The data presented here, based on 15 individual samples spanning from the 24th week of gestation to term with repeated measurement of five psychological dimensions including measures of stress and well-being, represent one of the most comprehensive assessments to date of the association between maternal psychological factors and cortisol during pregnancy. However, it is not without its limitations, including methodological issues related to the timing of saliva collection both in terms of gestational period and time of day. Reliance on an initial measurement point mid-way through pregnancy raises the possibility that significant associations may have been evident earlier in gestation. There is one report of a near significant (p = 0.06) association between cortisol levels in early pregnancy (8 to 19 weeks gestation) and more negative life events (Obel et al. 2005) and another significant relation between cortisol and trait anxiety (p < .05) (Pluess et al. 2010) during a similar gestational time window (10 to 20 weeks gestation). Significant associations did not persist when evaluated again later in pregnancy in either study. In contrast, other studies that have included evaluation of these associations as early as 13 weeks (Goedhart et al. 2010), 15 weeks (Davis and Sandman 2010; Harville et al. 2009), or 17 weeks (Sikkema et al. 2001) have not found significant associations between cortisol and psychological measures and therefore an overall answer to this question in early pregnancy remains unclear.

In addition, the current study relied on cortisol samples collected in mid-afternoon. Individual variation in HPA axis activity is most optimally indexed by multiple measurements reflective of the cortisol awakening response or diurnal secretory pattern, both of which are maintained during pregnancy (Allolio et al 1990; de Weerth and Buitelaar 2005a; Harville et al 2007). The studies which found associations earlier in pregnancy included a morning cortisol sample (Obel et al. 2005) or multiple measures to assess the cortisol awakening response (Pluess et al. 2010). Although, another study that employed a highly intensive cortisol sampling design (i.e., 7 samples per day, collected every 2 h from 8 a.m. to 8 p.m.) yielding morning levels and diurnal slope estimates during three gestational periods (i.e., 15 to 17 weeks, 27 to 28 weeks, and 37 to 38 weeks) failed to reveal any significant associations between cortisol values and maternal stress measures (Gutteling et al. 2006).

It is also possible that studies of the type reported here which involve measurement under baseline conditions do not adequately reflect situations in which the HPA axis is sufficiently activated to reveal an association with measures of maternal psychological state. However, in a study of pregnant women awaiting amniocentesis, during which one would assume significant activation of the stress response system, serum cortisol levels were only modestly associated with maternal state anxiety (r = 0.18) (Sarkar et al. 2006). Further, HPA axis reactivity to physical and psychological stressors is attenuated with advancing gestation (de Weerth and Buitelaar 2005b; de Weerth et al. 2007; Entringer et al. 2010; Fink et al. 2010; Magiakou et al. 1996; Nierop et al. 2008), and thus may limit observed variation in reactivity compared to that measured in a non-pregnant sample.

Further, it is important to reiterate that the current findings are generated from a sample of healthy women of relative socioeconomic advantage, raising questions of generalizability to either clinical psychiatric populations or those under economic duress. There may be a behavioral distress threshold below which the activity of the HPA and distress measures is uncoupled but above which there is a significant change in one is associated with changes in the other. Results based on clinical or disadvantaged groups are mixed. Salivary cortisol levels at 36 weeks gestation were not elevated in a sample of women with diagnosed depression and anxiety disorders compared to controls, although a small sub-sample of women with comorbid diagnosis (n = 9) had higher levels of cortisol than controls or either group with a single diagnosis (Evans et al. 2008). Another study comparing the cortisol awakening response at 25 and 33 weeks gestation revealed no differences between women who were clinically depressed and non-depressed controls (Shea et al. 2007). With respect to differences related to demographic factors, a large epidemiological study of nearly 1,600 pregnant women found that the higher levels of stress reported by unmarried, African-American, or young women was not reflected by differences in cortisol levels (Harville et al. 2009).

In summary, empirical evidence is lacking in support of a dose-response association between maternal cortisol and self-reported psychological state either earlier in pregnancy, when measured at different time of day, or in women who are exposed to more chronic psychological or socioeconomic risk and does not contraindicate the findings reported here. However, this should not be interpreted to suggest that maternal cortisol itself may not provide the fetus with an important signal as there is evidence of meaningful linkages between maternal cortisol and development which have only recently begun to be fully explored. Maternal cortisol has been shown to have facilitative effects on maturation of the fetal brain and timing of delivery (Sandman et al. 2006; Buss et al. 2009) and impacts infant behavioral and physiological responses to stress (Davis et al. 2011). Higher maternal cortisol in late pregnancy has been associated with more advanced physical and neuromuscular maturation in the neonate and mental development scores on the Bayley Scales at 12 months (Davis and Sandman 2010; Ellman et al. 2008) while the direction of these associations is reversed earlier in pregnancy (Davis and Sandman 2010). The potential influence of maternal cortisol is underscored by findings of the current study for the moderate to strong intra-individual stability in cortisol between 24 and 38 weeks gestation, and in other studies that have measured cortisol longitudinally beginning earlier in pregnancy (Davis and Sandman 2010; Gutteling et al. 2006).

Transduction of maternal psychological functions to the intrauterine environment requires a physiological signal. This study adds to the existing, but generally unacknowledged literature, that maternal salivary cortisol does not necessarily correspond to self-reported maternal psychological stress or well-being during pregnancy. This suggests that any observation of links between self-reported maternal psychological state and infant developmental outcomes requires additional hypotheses to identify potential mediating pathways.

ACKNOWLEDGEMENTS

This research was supported by National Institute of Child Health and Human Development grant 2R01 HD27592, awarded to J. A. DiPietro.

Footnotes

DISCLOSURE: None of the authors have a conflict of interest.

References

  1. Allolio B, Hoffmann J, Linton EA, Winkelmann W, Kusche M, Schulte HM. Diurnal salivary cortisol patterns during pregnancy and after delivery: Relationship to plasma corticotrophin-releasing-hormone. Clin Endocrinol. 1990;33:279–289. doi: 10.1111/j.1365-2265.1990.tb00492.x. [DOI] [PubMed] [Google Scholar]
  2. Buss C, Entringer S, Reyes J, Chicz-DeMet A, Sandman C, Waffarn F, Wadhwa P. The maternal cortisol awakening response in human pregnancy is associated with length of gestation. Am J Obstet Gynecol. 2009;201:398, e1–e8. doi: 10.1016/j.ajog.2009.06.063. [DOI] [PubMed] [Google Scholar]
  3. Chan E, Smith R, Lewin T, Brinsmead M, Zhang H, Cubis J, Thornton K, Hurt D. Plasma corticotropin-releasing hormone B-endorphin and cortisol inter-relationships during human pregnancy. Acta Endocrinol. 1993;128:339–344. doi: 10.1530/acta.0.1280339. [DOI] [PubMed] [Google Scholar]
  4. Cottrell E, Seckl J. Prenatal stress, glucocorticoids and the programming of adult disease. Frontiers Behav Neurosci. 2009;3:1–9. doi: 10.3389/neuro.08.019.2009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Davis E, Sandman C. The timing of prenatal exposure to maternal cortisol and psychosocial stress is associated with human infant cognitive development. Child Dev. 2010;81:131–148. doi: 10.1111/j.1467-8624.2009.01385.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Davis E, Glynn L, Waffarn F, Sandman C. Prenatal maternal stress programs infant stress regulation. J Child Psychol Psychiat. 2011;52:119–129. doi: 10.1111/j.1469-7610.2010.02314.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. de Weerth C, Buitelaar J. Cortisol awakening response in pregnant women. Psychoneuroendocrinology. 2005a;30:902–907. doi: 10.1016/j.psyneuen.2005.05.003. [DOI] [PubMed] [Google Scholar]
  8. de Weerth C, Buitelaar J. Physiological stress reactivity in human pregnancy - a review. Neurosci Biobehav Rev. 2005b;29:295–312. doi: 10.1016/j.neubiorev.2004.10.005. [DOI] [PubMed] [Google Scholar]
  9. de Weerth C, Gispen-de Weid C, Jansen L, Buitelaar J. Cardiovascular and cortisol responses to a psychological stressor during pregnancy. Acta Obstet Gynecol Scand. 2007;86:1181–1192. doi: 10.1080/00016340701547442. [DOI] [PubMed] [Google Scholar]
  10. de Wit M, Pouwer F, Gemke RJ, Delmarre-van de Waal HA, Snoek FJ. Validation of the WHO-5 Well-Being Index in adolescents with type I diabetes. Diabetes Care. 2007;30:2003–2006. doi: 10.2337/dc07-0447. [DOI] [PubMed] [Google Scholar]
  11. DiPietro J, Christensen A, Costigan K. The Pregnancy Experience Scale - Brief version. J Psychosom Obstet Gynaecol. 2008;29:262–267. doi: 10.1080/01674820802546220. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. DiPietro J, Costigan K, Kivlighan K, Chen P, Laudenslager M. Maternal salivary cortisol differs by fetal sex during the second half of gestation. Psychoneuroendocrinology. 2011;36:588–591. doi: 10.1016/j.psyneuen.2010.09.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. DiPietro J, Ghera M, Costigan K, Hawkins M. Measuring the ups and downs of pregnancy. J Psychosom Obstet Gynaecol. 2004;25:189–201. doi: 10.1080/01674820400017830. [DOI] [PubMed] [Google Scholar]
  14. DiPietro J, Kivlighan K, Costigan K, Rubin S, Shiffler D, Henderson J, Pillion JP. Prenatal antecedents of newborn neurological maturation. Child Dev. 2010;81:115–130. doi: 10.1111/j.1467-8624.2009.01384.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Dunkel-Schetter C. Psychological science on pregnancy: Stress processes, biopsychosocial models, and emerging research issues. Annu Rev Psychol. 2011;62:531–558. doi: 10.1146/annurev.psych.031809.130727. [DOI] [PubMed] [Google Scholar]
  16. Eastman N. Expectant motherhood. 2nd ed Little, Brown, and Company; Boston, MA: 1951. [Google Scholar]
  17. Ellman L, Schetter C, Hobel C, Chicz-DeMet A, Glynn L, Sandman C. Timing of fetal exposure to stress hormones: Effects on newborn physical and neuromuscular maturation. Dev Psychobiol. 2008;50:232–241. doi: 10.1002/dev.20293. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Entringer S, Buss C, Shirtcliff E, Cammack A, Yim I, Chicz-Demet A, Sandman C, Wadhwa P. Attentuation of maternal psychophysiological stress responses and the maternal cortisol awakening response over the course of human gestation. Stress. 2010;13:258–268. doi: 10.3109/10253890903349501. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Evans L, Myers M, Monk C. Pregnant women’s cortisol is elevated with anxiety and depression, but only when comorbid. Arch Womens Ment Health. 2008;11:239–248. doi: 10.1007/s00737-008-0019-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Field T, Diego M. Cortisol: the culprit prenatal stress variable. Int J Neurosci. 2008;118:1181–1205. doi: 10.1080/00207450701820944. [DOI] [PubMed] [Google Scholar]
  21. Fink N, Urech C, Berger C, Hoesli I, Holzgreve W, Bitzer J, Alder J. Maternal laboratory stress influences fetal neurobehavior: cortisol does not provide all answers. J Matern-Fetal Neonatal Med. 2010;23:488–500. doi: 10.3109/14767050903300985. [DOI] [PubMed] [Google Scholar]
  22. Gennaro S, Hennessy M. Psychological and physiological stress: impact on preterm birth. J Obstet Gynecol Neonatal Nurs. 2003;32:668–675. doi: 10.1177/0884217503257484. [DOI] [PubMed] [Google Scholar]
  23. Gitau R, Cameron A, Fisk N, Glover V. Fetal exposure to maternal cortisol. Lancet. 1998;352:707–708. doi: 10.1016/S0140-6736(05)60824-0. [DOI] [PubMed] [Google Scholar]
  24. Goedhart G, Vrijkotte T, Roseboom T, van der Wal M, Cuijpers P, Bonsel G. Maternal cortisol and offspring birthweight: results from a large prospective cohort study. Psychoneuroendocrinology. 2010;35:644–652. doi: 10.1016/j.psyneuen.2009.10.003. [DOI] [PubMed] [Google Scholar]
  25. Gutteling B, de Weerth C, Zandbelt N, Mulder E, Visser G, Buitelaar J. Does maternal prenatal stress adversely affect the child’s learning and memory at age six? J Abnorm Child Psychol. 2006;34:789–798. doi: 10.1007/s10802-006-9054-7. [DOI] [PubMed] [Google Scholar]
  26. Harville E, Savitz D, Dole N, Herring A, Thorp J, Light K. Patterns of salivary cortisol secretion in pregnancy and implications for assessment protocols. Biol Psychol. 2007;74:85–91. doi: 10.1016/j.biopsycho.2006.07.005. [DOI] [PubMed] [Google Scholar]
  27. Harville E, Savitz D, Dole N, Herring A, Thorp J. Stress questionnaires and stress biomarkers during pregnancy. J Womens Health. 2009;18:1425–1433. doi: 10.1089/jwh.2008.1102. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Heun R, Burkat M, Maier W, Bech P. Internal and external validity of the WHO Well-Being Scale in the elderly general population. Acta Psychiat Scand. 1999;99:171–178. doi: 10.1111/j.1600-0447.1999.tb00973.x. [DOI] [PubMed] [Google Scholar]
  29. King N, Chambers J, O’Donnell K, Jayaweera S, Williamson C, Glover V. Anxiety, depression and saliva cortisol in women with a medical disorder during pregnancy. Arch Womens Ment Health. 2010;13:339–345. doi: 10.1007/s00737-009-0139-5. [DOI] [PubMed] [Google Scholar]
  30. Kivlighan K, DiPietro J, Costigan K, Laudenslager M. Diurnal rhythm of cortisol during late pregnancy: associations with maternal psychological well-being and fetal growth. Psychoneuroendocrinology. 2008;33:1225–1235. doi: 10.1016/j.psyneuen.2008.06.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Kramer M, Lydon J, Seguin L, Goulet L, Kahn S, McNamara H, Genest J, Dassa C, Chen M, Sharma S, Meaney M, Thomson S, Van Uum S, Koren G, Dahhou M, Lamroureux J, Platt R. Stress pathways to spontaneous preterm birth: the role of stressors, psychological distress, and stress hormones. Am J Epidemiol. 2009;169:1319–1326. doi: 10.1093/aje/kwp061. [DOI] [PubMed] [Google Scholar]
  32. Magiakou M, Mastorakos G, Rabin D, Margioris A, Dubbert B, Calogero A, Tsigos C, Munson P, Chrousos G. The maternal hypothalamic-pituitary-adrenal axis in the third trimester of human pregnancy. Clin Endocrinol. 1996;44:419–428. doi: 10.1046/j.1365-2265.1996.683505.x. [DOI] [PubMed] [Google Scholar]
  33. Mastorakos G, Ilias I. Maternal and fetal hypothalamic-pituitary-adrenal axes during pregnancy and postpartum. Ann N Y Acad Sci. 2003;997:136–149. doi: 10.1196/annals.1290.016. [DOI] [PubMed] [Google Scholar]
  34. Mendelson T, DiPietro J, Costigan K, Chen P, Henderson J. Associations of maternal psychological factors with umbilical and uterine blood flow. J Psychosom Obstet Gynaecol. 2011;32:3–9. doi: 10.3109/0167482X.2010.544427. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Mercer R, Ferketich S. Stress and social support as predictors of anxiety and depression during pregnancy. Adv Nurs Sci. 1988;10:36–39. doi: 10.1097/00012272-198801000-00008. [DOI] [PubMed] [Google Scholar]
  36. Mosack V, Shore E. Screening for depression among pregnant and postpartum women. J Community Health Nurs. 2006;23:37–47. doi: 10.1207/s15327655jchn2301_4. [DOI] [PubMed] [Google Scholar]
  37. Mulder E, Robles de Medina P, Huizink A, Van den Bergh B, Buitelaar J, Visser G. Prenatal maternal stress: effects on pregnancy and the (unborn) child. Ear Hum Dev. 2002;70:3–14. doi: 10.1016/s0378-3782(02)00075-0. [DOI] [PubMed] [Google Scholar]
  38. Neu M, Goldstein M, Gao D, Laudenslager M. Salivary cortisol in preterm infants: validation of a simple method for collecting saliva for cortisol determination. Ear Hum Dev. 2007;83:47–54. doi: 10.1016/j.earlhumdev.2006.04.003. [DOI] [PubMed] [Google Scholar]
  39. Nierop A, Wirtz P, Bratsikas A, Zimmermann R, Ehlert U. Stress-buffering effects of psychosocial resources on physiological and psychological stress response in pregnant women. Biol Psychol. 2008;78:261–268. doi: 10.1016/j.biopsycho.2008.03.012. [DOI] [PubMed] [Google Scholar]
  40. Obel C, Hedegaard M, Henriksen T, Secher N, Olsen J, Levine S. Stress and salivary cortisol during pregnancy. Psychoneuroendocrinology. 2005;30:647–656. doi: 10.1016/j.psyneuen.2004.11.006. [DOI] [PubMed] [Google Scholar]
  41. Petraglia F, Florio P, Nappi C, Genazzani A. Peptide signaling in human placenta and membranes: autocrine, paracrine, and endocrine mechanisms. Endocr Rev. 1996;17:156–186. doi: 10.1210/edrv-17-2-156. [DOI] [PubMed] [Google Scholar]
  42. Petraglia F, Hatch M, Lapinski R, Stomati M, Reis F, Cobellis L, Berkowitz G. Lack of effect of psychosocial stress on maternal corticotropin-releasing factor and catecholamine levels at 28 weeks gestation. J Soc Gynecol Investig. 2001;8:83–88. [PubMed] [Google Scholar]
  43. Pluess M, Bolten M, Pirke K, Hellhammer D. Maternal trait anxiety, emotional distress, and salivary cortisol in pregnancy. Biol Psychol. 2010;83:169–175. doi: 10.1016/j.biopsycho.2009.12.005. [DOI] [PubMed] [Google Scholar]
  44. Pluess M, Wurmser H, Buske-Kirschbaum A, Papouse M, Pirke K, Hellhammer D, Bolten M. Positive life events predict salivary cortisol in pregnant women. Psychoneuroendocrinology. 2012;37:1336–1340. doi: 10.1016/j.psyneuen.2012.01.006. [DOI] [PubMed] [Google Scholar]
  45. Radloff L. The CES-D scale: A self-report depression scale for research in the general population. Appl Psychol Meas. 1977;1:385–401. [Google Scholar]
  46. Rothenberger S, Moehler E, Reck C, Resch R. Prenatal stress: Course and interrelation of emotional and physiological stress measures. Psychopathology. 2011;44:60–67. doi: 10.1159/000319309. [DOI] [PubMed] [Google Scholar]
  47. Sandman C, Glynn L, Schetter C, Wadwha P, Garite T, Chicz-DeMet A, Hobel C. Elevated maternal cortisol early in pregnany predicts third trimester levels of placental corticotropin releasing hormone (CRH): priming the placental clock. Peptides. 2006;27:1457–1463. doi: 10.1016/j.peptides.2005.10.002. [DOI] [PubMed] [Google Scholar]
  48. Sandman C, Wadhwa P, Chica-DeMet A, Dunkel-Schetter C, Porto M. Maternal stress, HPA activity, and fetal/infant outcome. Ann N Y Acad Sci. 1997;814:266–275. doi: 10.1111/j.1749-6632.1997.tb46162.x. [DOI] [PubMed] [Google Scholar]
  49. Sarkar P, Bergman K, Fisk N, Glover V. Maternal anxiety at amniocentesis and plasma cortisol. Prenat Diag. 2006;26:505–509. doi: 10.1002/pd.1444. [DOI] [PubMed] [Google Scholar]
  50. Shea A, Streiner D, Fleming A, Kamath M, Broad K, Steiner M. The effect of depression, anxiety and early life trauma on the cortisol awakening response during pregnancy: preliminary results. Psychoneuroendocrinology. 2007;32:1013–1020. doi: 10.1016/j.psyneuen.2007.07.006. [DOI] [PubMed] [Google Scholar]
  51. Sikkema J, Robles de Medina P, Schaad R, Mulder E, Bruinse H, Buitelaar J, Visser G, Franx A. Salivary cortisol levels and anxiety are not increased in women destined to develop preeclampsia. J Psychosom Res. 2001;50:45–49. doi: 10.1016/s0022-3999(00)00208-7. [DOI] [PubMed] [Google Scholar]
  52. Spielberger C. Manual for the State-Trait Anxiety Inventory (Form Y) Mind Garden, Inc; Palo Alto, CA: 1983. [Google Scholar]
  53. Stalla G, Bost H, Stalk J, Kaliebe T, Dorr H, Pfeiffer D, Werder K, Muller O. Human corticotropin-releasing hormone during pregnancy. Gynecol Endocrinol. 1989;3:1–10. doi: 10.3109/09513598909152447. [DOI] [PubMed] [Google Scholar]
  54. Vining R, McGinley R. The measurement of hormones in saliva: possibilities and pitfalls. J Steroid Biochem. 1987;27:81–94. doi: 10.1016/0022-4731(87)90297-4. [DOI] [PubMed] [Google Scholar]
  55. Wadhwa P. Psychoneuroendocrine processes in human pregnancy influence fetal development and health. Psychoneuroendocrinology. 2005;30:724–743. doi: 10.1016/j.psyneuen.2005.02.004. [DOI] [PubMed] [Google Scholar]
  56. Wadhwa P, Dunkel-Schetter C, Chicz-deMet A, Porto M, Sandman C. Prenatal psychosocial factors and the neuroendocrine axis in human pregnancy. Psychosom Med. 1996;58:432–446. doi: 10.1097/00006842-199609000-00006. [DOI] [PubMed] [Google Scholar]
  57. Wadhwa P, Entringer S, Buss C, Lu M. The contribution of maternal stress to preterm birth: issues and considerations. Clin Perinatol. 2011;38:351–384. doi: 10.1016/j.clp.2011.06.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. World Health Organization . Well-being measures in primary health care: the DepCare project. Stockholm, Sweden: 2008. [Google Scholar]

RESOURCES